News

May 24, 2016May 24, 2016

Malignant Mesothelioma May be Prevented, Fought with Help from Food Compounds

News

Micronutrients found in certain foods and beverages of plant origin have anti-inflammatory and anti-tumoral properties that may help prevent or fight malignant mesothelioma (MM), according to the study “The Potential ... Read more

May 19, 2016May 19, 2016

Family History of Mesothelioma Raises a Person’s Risk for the Disease, Study Reports

News

A population-based study from Sweden found that a family history of mesothelioma, specifically in parents and siblings, is a risk factor for mesothelioma in a person. The study, “Incidence and familial risk of ... Read more

May 16, 2016May 16, 2016

MicroRNA Seen to Limit Tumor Growth, Invasion in Early Malignant Pleural Mesothelioma Study

News

A microRNA, miR-591, inhibits malignant pleural mesothelioma (MPM) cell proliferation and invasion, according to the study “Overexpression of micro ribonucleic acid-591 inhibits cell proliferation and invasion of malignant pleural mesothelioma cells,” ... Read more

May 13, 2016May 13, 2016

Unsound Asbestos ‘Facts’ Putting Workers at Risk and Hurting Mesothelioma Patients, Doctor Says

News

A doctor with the Institute of Occupational Medicine at Charite University Hospital in Berlin contends that unfair requirements are being used to deny mesothelioma patients compensation due to asbestos exposure, and misleading scientific “facts” about ... Read more

May 12, 2016May 12, 2016

Data from Phase 2 Study of Pre-surgery Treatment in MPM Patients Presented at iMig 2016

News

Dr. Raphael Bueno, chief of Thoracic Surgery at Brigham and Women’s Hospital (BWH) in Boston, recently presented clinical data of the ongoing, Verastem-sponsored Phase 2 clinical trial of a neoadjuvant treatment in people with ... Read more

May 11, 2016May 11, 2016

1st Patient with MPM Enrolls in Phase 3 Study of Nintedanib as a First-line Treatment

News

Boehringer Ingelheim announced the enrollment of a first patient in the LUME-Meso clinical trial, a Phase 2/3 study evaluating the safety and efficacy of nintedanib (Vargatef) in combination with pemetrexed/cisplatin, followed by ... Read more

May 10, 2016May 10, 2016

Monoclonal Antibody Combo Therapy Seen to Slow Malignant Mesothelioma Growth in Mice

News

Monoclonal antibodies against CD26 may be a new adjuvant therapy in the treatment of malignant mesothelioma (MM) patients, according to a study published in the journal Cancer Cell International, and titled ... Read more

May 9, 2016May 9, 2016

FDA Approves Request to Test EZH2 Inhibitor, Tazemetostat, in Mesothelioma Patients

News

The U.S. Food and Drug Administration (FDA) recently accepted an Investigational New Drug (IND) application for tazemetostat as a potential treatment of mesothelioma in adults. The decision allows Epizyme, the company developing tazemetostat, ... Read more

May 6, 2016May 6, 2016

MicroRNA Reported to Halt Growth of Malignant Mesothelioma Tumors in Mouse Model

News

A small RNA molecule, microRNA-126 (MIR126), has a protective role in malignant mesothelioma mouse models by triggering a cellular pathway, called autophagy, that leads to the metabolic reprogramming of cancer cells and ... Read more

May 5, 2016May 5, 2016

Experience of Surgical Team Key Factor in Pleural Mesothelioma Care, Doctors Stress

News

Surgery plans a vital role in the care of malignant pleural mesothelioma, researchers from Baylor College of Medicine state, stressing that such operations should be restricted to experienced surgeons with excellent track ... Read more